5 stocks to buy with £20k in a Stocks and Shares ISA

Rupert Hargreaves looks at five stocks he’d buy today for his Stocks and Shares ISA with £20,000 and a long-term outlook.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Using a Stocks and Shares ISA is one of the best ways to invest in the market. Any income or capital gains earned on assets held within one of these wrappers doesn’t attract any further tax. Investors don’t even need to declare the income on their tax returns.

I try to make the most of my £20k ISA allowance every year as soon as possible. Here are five stocks I’d buy with my latest allowance today.

Stocks and Shares ISA

Thanks to the tax benefits of an ISA, I think they’re the perfect wrappers in which to own income investments.

I’d buy FTSE 100 healthcare stocks Hikma and GlaxoSmithKline with a portion of my £20,000 investment on this theme. 

Hikma manufactures a range of generic, low-cost medications. Meanwhile, Glaxo is more of a healthcare conglomerate, with treatments spanning from vaccines to oncology and an extensive consumer healthcare portfolio. This mixture provides healthy cash flows to support the firm’s large dividend yield of 5.6%. 

Hikma is more of a dividend growth investment. The stock offers a dividend yield of 1.5%, at the time of writing. Over the past five years, as the company’s earnings have expanded, its per-share dividend has grown at a compound annual rate of nearly 10%. As such, over the long term, I think this could be a fantastic income investment. 

Of course, these assets aren’t risk-free. Dividends are paid out of profits, and if the income at Glaxo or Hikma falls, the payouts could be slashed. Any number of factors could lead to this outcome. A sudden unforeseen economic downturn, legal battle, or higher than expected costs could significantly reduce earnings power. 

Despite these risks, I’d buy Glaxo and Hikma for my Stocks and Shares ISA portfolio today. 

Steady income 

Two other income plays I’d buy are Assura and Airtel Africa. Assura owns medical facilities in the UK, which it leases to healthcare providers. Airtel owns mobile phone towers across Africa.

The stocks offer dividend yields of 3.7% and 4.9% respectively. These payouts aren’t guaranteed. Both companies also use a lot of debt to fund their operations, which could limit their ability to grow the distributions in the long run. 

Still, I’d buy the equities for my Stocks and Shares ISA due to their cash flows from stable infrastructure assets. 

Growth investment 

The final company I’d buy for my £20,000 portfolio is a growth investment. Spirent Communications develops technology for the communications industry, in particular equipment used in 5G networks.

The 5G global services market is expected to grow at a compound annual growth rate of 46.2% from 2021 to 2028. I think if Spirent can grab just a tiny share of this market, it could be an excellent growth investment. 

The main challenge the business faces is standing out in such a competitive market. The market may also not live up to growth expectations. This could mean Spirent’s long-term growth is lower than expected. 

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British pound data
Investing Articles

The red lights are flashing again for Lloyds’ share price! Here’s why

Lloyds' share price continues to defy gravity. But Royston Wild thinks it's only a matter of time before the FTSE…

Read more »

Aston Martin DBX - rear pic of trunk
Investing Articles

Aston Martin shares are now only 41p!

Aston Martin shares just dropped to around the 41p mark! Is this a brilliant buying opportunity or a stock that…

Read more »

Artillery rocket system aimed to the sky and soldiers at sunset.
Investing Articles

Up 325% in 5 years! But are BAE System shares still a no-brainer buy?

BAE Systems shares would have been a brilliant buy five years ago. But could they still offer excellent returns if…

Read more »

Investing Articles

How much do you need to invest each month into FTSE 100 shares to aim for a million?

Simply by putting a few hundred pounds a month into FTSE 100 shares, how might someone aim to become a…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

£10,000 invested in BAE shares at the beginning of 2026 is now worth…

Paul Summers tips his hat to those who invested in BAE Systems shares when markets opened back up in January.…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

What size ISA do you need for £250-a-week retirement income?

Harvey Jones outlines the advantages of investing in a Stocks and Shares ISA rather than leaving money in cash, and…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

£5,000 invested in Legal & General shares 5 years ago is now worth…

Harvey Jones crunches the numbers to show how much an investor would have earned from Legal & General shares lately,…

Read more »

Investing Articles

Just check out the latest bumper forecasts for Lloyds, NatWest and Barclays shares

Harvey Jones says Barclays shares have had a terrific year and there could be more action to come. So what's…

Read more »